P473 Infliximab is more immunogenic and reaches lower trough levels in ulcerative colitis patients compared to Crohn's disease patients

✍ Scribed by Bar-yoseph, H.; Chowers, Y.; Ben-Horin, S.; Waterman, M.

• Book ID: 123333373
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 53 KB
• Volume: 7
• Category: Article
• ISSN: 1873-9946
• DOI: 10.1016/S1873-9946(13)60494-8